Navigating the Emergency Department: ADLM Updates Guidance on Drug Testing
It's a critical moment when someone arrives at the Emergency Department (ED) with symptoms that could be related to drug use. Accurate drug testing is absolutely vital, and the Association for Diagnostics & Laboratory Medicine (ADLM) has just released updated guidance to help healthcare professionals make the best decisions.
This new guidance is designed to assist laboratory medicine professionals and clinicians in selecting the most appropriate drug tests. By working together, they can ensure patients receive the most personalized care possible.
Drug testing plays a vital role in patient care. Imagine a pediatric patient with an altered mental state. A positive drug test could prevent unnecessary procedures and alert healthcare providers to involve child protective services.
But here's where it gets controversial: The landscape of drug use and testing has changed dramatically. Back in 2003, ADLM first released its guidance. Since then, the situation has become far more complex. The rise of synthetic opioids like fentanyl around 2013 has dramatically impacted the illegal drug supply. New designer drugs are constantly emerging, designed to evade existing drug laws. Simultaneously, the use of some older drugs, like tricyclic antidepressants, has decreased to the point where routine testing is no longer as useful.
And this is the part most people miss: The technology used for drug testing has also evolved significantly. Immunoassays, the standard testing method, have improved. Many healthcare institutions now have access to mass spectrometry, a more powerful method that can detect drugs that immunoassays might miss.
To address these changes, a team of experts from ADLM's Academy of Diagnostics & Laboratory Medicine has updated the original 2003 guidance. The key recommendations include:
- Collaboration is Key: Laboratory experts and ED clinicians should work together to ensure drug tests are used correctly for both adults and children. Labs should educate ED staff about the tests' capabilities and limitations and be available to help interpret results.
- Stay Up-to-Date: Clinical laboratories and EDs should regularly review their drug test menus and protocols, updating them to reflect local drug use trends. They should only include tests that will directly influence patient care.
- Consider Advanced Methods: While mass spectrometry is more expensive, it should be considered for specific populations, such as pediatric patients, and in situations where immunoassays are insufficient and the test result will inform the patient's care.
According to the document authors, Drs. Christine L.H. Snozek, Matthew D. Krasowski, Jennifer M. Colby, Kamisha L. Johnson-Davis, Rebecca E. Bruccoleri, and Stacy E. Melanson, "Regardless of the method(s) offered, all laboratories should collaborate with ED leadership … to ensure test menus are up to date and reasonable for the patient population." They also emphasize the importance of collaboration between laboratories and EDs to educate clinical staff and develop optimal strategies to meet clinical needs.
What do you think? Do you agree with the recommendations for collaboration and the use of advanced testing methods? Share your thoughts in the comments below!
About the Association for Diagnostics & Laboratory Medicine (ADLM)
ADLM is dedicated to improving health through laboratory medicine. It unites over 70,000 professionals from 110 countries. The community focuses on various subdisciplines, including clinical chemistry, molecular diagnostics, and data science. ADLM has been advancing laboratory medicine since 1948 through collaboration and innovation.
Contact Information:
- Christine DeLong, Director, Editorial and Media Relations, (p) 202.835.8722, [email protected]
- Bill Malone, Senior Director, Strategic Communications, (p) 202.835.8756, [email protected]
